Navigation Links
PneumRx, Inc. Announces CE Mark Approval for Its RePneu® Lung Volume Reduction Coil (LVRC™) System
Date:10/13/2010

MOUNTAIN VIEW, Calif., Oct. 13 /PRNewswire/ -- PneumRx, Inc. (www.pneumrx.com), a medical device company dedicated to bringing innovation and improvements to the treatment of lung disease, today announced that it has received CE Mark approval for its RePneu Lung Volume Reduction Coil (LVRC) System to treat the later stages of emphysema.  

The RePneu LVRC System is a minimally invasive device intended to improve lung function in emphysema patients by brochoscopically implanting Nitinol coils into the lungs to compress damaged tissue (lung volume reduction) and restore elastic recoil to the healthier lung tissue.  This treatment offers a minimally invasive alternative to lung volume reduction surgery, and works independently of collateral ventilation.  

The CE mark approval enables PneumRx to move forward with commercialization in Europe and other select markets.  PneumRx intends to launch its RePneu LVRC System in Europe in the last quarter of 2010.  PneumRx plans to continue its ongoing partnership with physicians through training and by offering novel products for the diagnosis and treatment of lung disease.

"We are thrilled to have achieved this important milestone, and look forward to introducing our RePneu LVRC to the European market to help improve the lives of so many people who are suffering from emphysema and have few other viable treatment options," said Erin McGurk, President and CEO of PneumRx, Inc.  "We are extremely pleased with the significant improvements in pulmonary function tests, exercise tolerance, and quality of life experienced by our clinical trial patients, and expect to bring these same benefits to a broader population of emphysema patients with the commercialization of the RePneu LVRC System in Europe."

About PneumRx, Inc.

PneumRx, Inc. is a rapidly growing medical device company focused on the development and commercialization of innovative products to treat emphysema using minimally-invasive techniques.  It is a privately held company located in Mountain View, California.


'/>"/>
SOURCE PneumRx, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/28/2020)... ... January 28, 2020 , ... ... for Maternal-Fetal Medicine’s (SMFM) Pregnancy Meeting in Grapevine, Texas from February 5th ... benefits of a high-performance HD teleultrasound solution. RMTConnectTM allows users to ...
(Date:1/28/2020)... ... , ... According to the American Transplant Foundation, there are 114,000 people in ... surgery this year. Unfortunately, 20 people will die each day as their time passes ... from a lack of available donated organs, but mainly from cumbersome and complex transportation ...
(Date:1/28/2020)... ... January 28, 2020 , ... Knowing it can be difficult ... healthy changes, Isagenix International has launched several offerings, including Snack Bites, ... health and wellness company has also expanded its BEA™ Sparkling Energy Drink and ...
Breaking Medicine Technology:
(Date:1/24/2020)... ... January 24, 2020 , ... Devcool Inc ( http://www.devcool.com ... has completed its spin-off of HiPaaS, Inc ( http://www.hipaas.com ). HiPaaS Inc ... continues its growth and focuses on Healthcare consulting services. , With HiPaaS, ...
(Date:1/23/2020)... ... January 23, 2020 , ... ... scientific training, biomedical research, and patient care—today announced the recipients of the first-of-its-kind ... Equity in Science and Medicine. The awards aim to mitigate gender gaps in ...
(Date:1/23/2020)... ... January 23, 2020 , ... ... LLC, a first-of-its-kind, full-service pulmonology clinic based in Tulsa, to provide patients with ... MCNDOH patients will also have access to HGE Health’s digital symptom management platform, ...
(Date:1/23/2020)... ... January 23, 2020 , ... ... pledged to take action to improve diagnostic quality and safety by joining the ... most prominent organizations in healthcare and patient advocacy. , “Diagnostic error is one ...
(Date:1/23/2020)... SANDY SPRINGS, Ga. (PRWEB) , ... January 23, 2020 , ... ... Dr. Robyn McCalla to become a new member of their professional dental staff. ... of services, including general dentistry, cosmetic dentistry, emergency dentistry and restorative dentistry, ...
Breaking Medicine News(10 mins):